The Cardinal Group USA, LLC
Dana Niro is an accomplished Project Director with extensive experience in facilities and engineering within the biopharmaceutical sector. Currently at The Cardinal Group USA, LLC since November 2022, Dana has previously held significant roles at TScan Therapeutics and Magenta Therapeutics, contributing to major projects such as the $70 million renovation of Alnylam Pharmaceuticals in Cambridge. With a strong foundation in project management and engineering from earlier positions at Lend Lease, The Richmond Group, and Bovis Lend Lease, Dana has been involved in multi-million dollar expansions and renovations, demonstrating expertise in managing complex construction projects. Dana holds a Bachelor of Science degree in Construction Management and Business Management from Roger Williams University.